Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...
Stockhead on MSN
Biocurious: AI becomes the hidden helping hand in clinical trial design and analysis
Drug developers increasingly are harnessing AI to optimise clinical trial patient selection and to interpret results to ...
Whether metformin has a role as an add-on to insulin was examined in two recent studies: the Mity trial (Metformin in Women ...
According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million ...
Women with risk-based screening had about 30 cases of advanced cancer per 100,000 person-years, compared with 48 cases per ...
A federally funded clinical trial suggests knowing HIV viral load (number of HIV particles in the body) doesn’t improve the ...
Innovative approaches to making clinical studies more efficient and cost-effective were a central theme of the 2nd Annual COG ...
The clinical trial industry is at a critical juncture where traditional methods are proving insufficient for managing today’s ...
Tailoring breast cancer screening to a woman's individual cancer risk might work better than annual mammograms, researchers ...
7hon MSN
The Highly Anticipated “Triple Agonist” Weight Loss Med Is Almost Here—What Doctors Say About It
Phase 3 clinical trial results are out now.
AIwithCare features a software platform that uses generative AI to screen patients for clinical trial eligibility.
BOSTON, December 16, 2025--nChroma Bio ("nChroma"), a genetic medicines company advancing in vivo delivery of innovative cargoes to overcome the limitations of existing therapies, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results